Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,109.14
(
-0.24%
)
US TECH 100
25,918.50
(
-0.14%
)
Dow Jones
49,442.56
(
-0.01%
)
Brent Oil
91.16
(
0.53%
)
Bitcoin
75,665.77
(
-0.30%
)
News Focus
News Focus
Post# of 257431
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (5) Keep Next 10 Report Keyboard Shortcuts
Replies (5) Next 10 Prev Next

acgood

Send PM Follow Ignore
Followers 17
Posts 1093
Boards Moderated 0
Alias Born 05/12/2007

acgood

Re: ghmm post# 133142

Friday, 12/16/2011 1:37:05 PM

Friday, December 16, 2011 1:37:05 PM

Post# of 257431
the MRK BACE program is indeed from Ligand. Phase 1 single dose showed the 58% reduction mentioned in LGND 10k, Phase 1 multidose showed 90% reduction (November 2011 MRK slides), and phase 2 to start 2012.

As is the case for numerous of their programs, Ligand knows nothing more than what MRK has put out publicly.

Any comments here may have previously been disseminated on Twitter @BioDueDiligence or at www.biotechduediligence.com

Public Reply Private Reply New Post
Keep Last Read
Replies (5) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (5) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today